Availability and toxicity of Fe(II) and Fe(III) in Caco-2 cells
Wan-ling HE; Ying FENG; Xiao-li LI; Yan-yan WEI; Xiao-e YANG.
Journal of Zhejiang University. Science. B
; (12): 707-712, 2008.
Artículo en Inglés | WPRIM | ID: wpr-359381
Documentos relacionados
Current development of integrated web servers for preclinical safety and pharmacokinetics assessments in drug development.
Evaluation of ADMET Predictor in Early Discovery Drug Metabolism and Pharmacokinetics Project Work.
Prediction of Human Distribution Volumes of Compounds in Various Elimination Phases Using Physiologically Based Pharmacokinetic Modeling and Experimental Pharmacokinetics in Animals.
Body-on-a-chip systems for animal-free toxicity testing.
Training the next generation of pharmacometric modelers: a multisector perspective.
Low-dimensional neural ODEs and their application in pharmacokinetics.
ADMET evaluation in drug discovery. 11. PharmacoKinetics Knowledge Base (PKKB): a comprehensive database of pharmacokinetic and toxic properties for drugs.
Drug Disposition Classification Systems in Discovery and Development: A Comparative Review of the BDDCS, ECCS and ECCCS Concepts.
The Caco-2 cell monolayer: usefulness and limitations.
Influence of the microporous substratum and hydrodynamics on resistances to drug transport in cell culture systems: calculation of intrinsic transport parameters.